1. Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future
- Author
-
Mubasher Rehman, Sajid Hussain Shah, Muhammad Junaid, Isfahan Tauseef, Kashif Syed Haleem, and Bibi Aalia
- Subjects
0301 basic medicine ,medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,viruses ,coronavirus ,Review ,drugs ,03 medical and health sciences ,0302 clinical medicine ,Virology ,vaccine ,medicine ,Global health ,Intensive care medicine ,skin and connective tissue diseases ,nCoV ,business.industry ,SARS-CoV-2 ,fungi ,virus diseases ,COVID-19 ,body regions ,030104 developmental biology ,030220 oncology & carcinogenesis ,business - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019. It was first reported in Wuhan, China and has since become a global health concern. Keeping in view, the magnitude of the problem, scientists around the globe are working to develop effective therapeutic strategies. This review focuses on previous findings regarding SARS-CoV, which may prove helpful in future research on SARS-CoV-2. In addition, it also highlights recent developments in medicine and biotechnology toward developing effective drugs and vaccines against SARS-CoV-2. This review will analyze available data on this topic and will help researchers develop new thoughts using information already available as a step toward developing novel therapeutic strategies against SARS-CoV-2.
- Published
- 2020